Orris

Do hiv patient lives

Reading File
Finding Sources
Searching PubMed

HIV AND life expectancy

Searching the Web

HIV treatment life expectancy people living with HIV official source

Yes. People with HIV can live long, full lives, especially when they start and continue antiretroviral treatment (ART).
With HIV medicines keeping the virus suppressed, life expectancy can approach that of people without HIV. HIV is now generally a manageable long-term condition, though there is not yet a cure.
Key steps:
  • Start ART as soon as possible and take it every day as prescribed.
  • Attend regular HIV-clinic visits and blood tests.
  • If the viral load becomes undetectable and stays that way, HIV is not sexually transmitted to partners: “undetectable = untransmittable” (U=U).
  • Get help promptly for symptoms such as prolonged fever, weight loss, severe diarrhea, breathing problems, or confusion.
A medical textbook notes that people with virologically controlled HIV have life expectancy approaching that of the general population (Goldman-Cecil Medicine, HIV section).

Find the latest HIV treatment guidelines

Reading File
Reading File
Searching the Web

latest adult HIV treatment guidelines antiretroviral therapy WHO 2025 NIH 2025 official

Finding Sources
Searching PubMed

HIV antiretroviral therapy guideline

Reading Web Page

https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guid…

Reading Article

PMID: 39616604

Reading Article

PMID: 41088922

Searching the Web

site:who.int 2025 HIV clinical guidelines treatment antiretroviral WHO recommendations overview PDF

Reading Web Page

https://clinicalinfo.hiv.gov/en/guidelines

Searching PubMed

HIV treatment guideline

The newest major HIV treatment guidance I found is the WHO updated clinical-management recommendations, published in December 2025. It updates global treatment, prevention of vertical transmission, and tuberculosis prevention guidance. WHO continues to recommend dolutegravir-based ART as the preferred initial and subsequent treatment approach, and identifies darunavir/ritonavir as the preferred protease-inhibitor option when one is needed. WHO’s update summary provides the key changes.
For United States adult and adolescent care, the current NIH/HHS Adult and Adolescent ARV Guidelines were updated September 25, 2025. They recommend:
  • ART for every person with HIV, started immediately or as soon as possible after diagnosis.
  • For most people, initial therapy with an integrase inhibitor-based regimen:
    • Bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC), or
    • Dolutegravir plus TAF/FTC, TDF/FTC, or TDF/lamivudine.
  • Dolutegravir/lamivudine can be appropriate for selected people, but not everyone.
  • Regimen choice must account for pregnancy, hepatitis B, kidney function, tuberculosis treatment, prior PrEP or long-acting cabotegravir exposure, drug interactions, and resistance testing. See the NIH initial-regimen guidance and rapid ART guidance.
The NIH guideline site also lists later 2026 updates for adult/adolescent opportunistic infections (May 28, 2026) and pediatric HIV treatment (June 25, 2026). Its guideline hub is the best U.S. source for current adult, pregnancy, child, and opportunistic-infection recommendations.
A recent independent practice guideline, the IAS-USA 2024 recommendations, published in 2025, similarly supports an initial regimen based on bictegravir or dolutegravir plus NRTIs, with long-acting injectable treatment as an option for selected people. Gandhi et al., JAMA 2025, PMID 39616604. The 2025 European AIDS Clinical Society update likewise recommends tenofovir plus emtricitabine/lamivudine with dolutegravir, bictegravir, or doravirine, with dolutegravir plus lamivudine as a two-drug option in suitable patients. Ambrosioni et al., HIV Medicine 2026, PMID 41088922.
These are clinician guidelines, not a substitute for an individual prescription. ART should be chosen with an HIV clinician after checking viral load, CD4 count, kidney/liver function, hepatitis B status, resistance results, current medicines, and pregnancy status.
This is a shared conversation. Sign in to Orris to start your own chat.